Skip to content

Study · Not a test of the peptide alone · 2008

2 results

Use of a low-dose ACTH stimulation test for diagnosis of hypoadrenocorticism in dogs.

Lathan P, Moore GE, Zambon S, Scott-Moncrieff JC

Journal of veterinary internal medicine1 Jul 2008Cited by 17 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Cosyntropin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Cosyntropin.

  1. 01AnimalNot a test of Cosyntropin aloneAnimal study (in vivo)Activity measurement

    In dogs with suspected Addison's disease, cortisol responses were equivalent at 5 microg/kg and 250 microg/dog (16.2+/-7.7 versus 15.9+/-6.3 microg/dL).

    In plain wordsIn dogs with suspected Addison's disease, the two cosyntropin doses produced equivalent cortisol responses.

    Outcome
    No significant changeDose equivalence of cortisol response
    Study

    dogn = 29

    Hospitalized dogs with suspected hypoadrenocorticism
    Comparator
    250 microg/dog cosyntropin
    Outcome group
    Adrenal Function · Endocrine and hormones

    Measurements

    90% CI lower
    91.2%
    Dose equivalence
    90% CI upper
    105.4%
    Dose equivalence

    Source sentences

    Summary
    In dogs with suspected Addison's disease, mean (+/-SD) cortisol responses to ACTH in the 5 microg/kg dose (16.2+/-7.7 microg/dL) and 250 microg/dog dose (15.9+/-6.3 microg/dL) were statistically equivalent (90% CI: 91.2-105.4%).
    3 context sentences
    Summary · context
    Eight healthy adult dogs and 29 hospitalized dogs with suspected hypoadrenocorticism.
    Summary · context
    Dogs received either 5 microg/kg or 250 microg/dog of cosyntropin on day 1 and the alternate dose on day 2.
    Summary · context
    Dogs with suspected Addison's disease received 2 ACTH stimulation tests, 24 hours apart, using either a dose of 5 microg/kg cosyntropin or 250 microg/dog on the 1st day and the alternate dose on the 2nd day.

    In this study, Cosyntropin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cosyntropin.

  2. 02AnimalNot a test of Cosyntropin aloneAnimal study (in vivo)Activity measurement

    In healthy dogs, post-cosyntropin cortisol on days 2 and 16 was equivalent to days 1 and 15 (90% CI 86.7-101.2%).

    In plain wordsIn healthy dogs, cortisol responses to cosyntropin were equivalent on consecutive testing days.

    Outcome
    No significant changeConsecutive-day stimulated cortisol equivalence
    Study

    dogn = 8

    Healthy adult dogs
    Comparator
    Days 1 and 15
    Outcome group
    Adrenal Function · Endocrine and hormones

    Source sentences

    Summary
    In healthy dogs, poststimulation cortisol concentrations on days 2 and 16 and days 1 and 15 were equivalent (90% confidence interval [CI]: 86.7-101.2%).
    3 context sentences
    Summary · context
    Eight healthy adult dogs and 29 hospitalized dogs with suspected hypoadrenocorticism.
    Summary · context
    Dogs received either 5 microg/kg or 250 microg/dog of cosyntropin on day 1 and the alternate dose on day 2.
    Summary · context
    Dogs with suspected Addison's disease received 2 ACTH stimulation tests, 24 hours apart, using either a dose of 5 microg/kg cosyntropin or 250 microg/dog on the 1st day and the alternate dose on the 2nd day.

    In this study, Cosyntropin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cosyntropin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:37 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.